- Home
- FSEA vs FLNA Comparison
FSEA vs FLNA Comparison
Compare FSEA & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FSEA | FLNA |
|---|---|---|
| Founded | 1890 | 1998 |
| Country | United States | United States |
| Employees | N/A | 20 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7M | 61.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | FSEA | FLNA |
|---|---|---|
| Price | $16.83 | $1.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.9K | ★ 346.0K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.13 | $1.16 |
| 52 Week High | $16.90 | $2.03 |
Technical Indicators
Market Signals| Indicator | FSEA | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 77.51 | 40.61 |
| Support Level | $16.60 | $1.16 |
| Resistance Level | N/A | $1.80 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 44.83 | 4.41 |
Price Performance
Historical ComparisonAbout FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.
About FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.